ArticleBiomedicines2022

The Class I HDAC Inhibitor Valproic Acid Strongly Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Immune System Activation.

Amber Blaauboer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.